Expression of notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function

Kidney International

Volumn 78, Issue 5, 2010, Pages 514-522

  Murea, Mariana ^a,c   Park, Jun Ki ^a   Sharma, Shuchita ^a   Kato, Hideki ^a   Gruenwald, Antje ^a   Niranjan, Thiruvur ^a   Si, Han ^a   Thomas, David B ^b   Pullman, James M ^b   Melamed, Michal L ^a   Susztak, Katalin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

albuminuria; cell signaling; chronic kidney disease; diabetic nephropathy; podocyte

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSCLEROSIS; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; RECEPTOR UPREGULATION;

EID: 77955654604     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.172     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention (CDC). State-specific trends in chronic kidney failure\United States, 1990-2001. MMWR Morb Mortal Wkly Rep 2004; 53: 918-920.
2. Mundel P, Schwarz K, Reiser J. Podocyte biology: a footstep further. Adv Nephrol Necker Hosp 2001; 31: 235-241.
3. Kriz W, Elger M, Hosser H et al. How does podocyte damage result in tubular damage? Kidney Blood Press Res 1999; 22: 26-36.
4. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307.
5. Ilagan MX, Kopan R. SnapShot: notch signaling pathway. Cell 2007; 128: 1246.
6. Kopan R, Cagan R. Notch on the cutting edge. Trends Genet 1997; 13: 465-467.
7. Cheng HT, Kim M, Valerius MT et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development (Cambridge, England) 2007; 134: 801-811.
8. Cheng HT, Kopan R. The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int 2005; 68: 1951-1952.
9. Cheng HT, Miner JH, Lin M et al. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development (Cambridge, England) 2003; 130: 5031-5042.
10. Kopan R, Cheng HT, Surendran K. Molecular insights into segmentation along the proximal-distal axis of the nephron. J Am Soc Nephrol 2007; 18: 2014-2020.
11. Chen L, Al-Awqati Q. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol 2005; 288: F939-F952.
12. Piscione TD, Wu MY, Quaggin SE. Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. Gene Expr Patterns 2004; 4: 707-711.
13. Niranjan T, Bielesz B, Gruenwald A et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298.
14. Waters AM, Wu MY, Onay T et al. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008; 19: 1139-1157.
15. Niranjan T, Murea M, Susztak K. The pathogenic role of notch activation in podocytes. Nephron 2009; 111: e73-e79.
16. Walsh DW, Roxburgh SA, McGettigan P et al. Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim Biophys acta 2008; 1782: 10-21.
17. Morrissey J, Guo G, Moridaira K et al. Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 2002; 13: 1499-1508.
18. Zavadil J, Cermak L, Soto-Nieves N et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23: 1155-1165.
19. Niimi H, Pardali K, Vanlandewijck M et al. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 2007; 176: 695-707.
20. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
21. Agarwal A, Nath KA. Effect of proteinuria on renal interstitium: effect of products of nitrogen metabolism. Am J Nephrol 1993; 13: 376-384.
22. Hozumi K, Negishi N, Suzuki D et al. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat Immunol 2004; 5: 638-644.
23. Sharma M, Fopma A, Brantley JG et al. Coexpression of Cux-1 and Notch signaling pathway components during kidney development. Dev Dyn 2004; 231: 828-838.
24. Vooijs M, Ong CT, Hadland B et al. Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development (Cambridge, England) 2007; 134: 535-544.
25. Kobayashi T, Terada Y, Kuwana H et al. Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008; 73: 1240-1250.
26. Giannico G, Yang H, Neilson EG et al. Dystroglycan in the diagnosis of FSGS. Clin J Am Soc Nephrol 2009; 4: 1747-1753.
27. van Es JH, van Gijn ME, Riccio O et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959-963.
28. Duncan AW, Rattis FM, Di Mascio LN et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6: 314-322.
29. Alonso L, Fuchs E. Stem cells in the skin: waste not, Wnt not. Genes Dev 2003; 17: 1189-1200.
30. Koop K, Eikmans M, Baelde HJ et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071.
31. Guan L, Dadparvar S, Reich P et al. Unrecognized renal transplants as a potential source of false-positive interpretation of FDG PET. Clin Nuclear Med 2003; 28: 655-657.
32. Eardley KS, Kubal C, Zehnder D et al. The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 2008; 74: 495-504.
33. Perneger TV. What's wrong with Bonferroni adjustments. BMJ (Clinical research ed) 1998; 316: 1236-1238.